Crohn’s Disease Exclusion Diet for the Treatment of Crohn’s Disease: Real-World Experience from a Tertiary Center
Journal of Clinical Medicine · 21.08.2023 · 12 (16) · 5428
DOI: 10.3390/jcm12165428 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 21.08.2023. Verfasst von Naomi Fliss-Isakov und 8 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Nestlé.
Abstract (Originalsprache)
The Crohn’s Disease (CD) exclusion diet (CDED) has been shown to induce remission in pediatric and adult patients with CD. In this retrospective cohort study, we describe our real-world experience with the CDED at the inflammatory bowel disease (IBD) unit of the Tel Aviv Medical Center between 2018–2021. CD patients with multiple clinical presentations and disease phenotypes who initiated the diet were included. Indications for treatment, medical and nutritional data were collected from dietician clinic visits and medical records. Clinical and biomarker responses were determined. The CDED was recommended to 220 CD patients. Seventy-two patients were included in the analysis for a clinically active disease (n = 48) or for remission maintenance (n = 24). Among patients with a clinically active disease, 62.5% of patients achieved clinical remission at week 6 and at week 12. A positive association between high adherence to the CDED and clinical remission at week 12 was observed (adjusted OR = 7.6, 95% CI 1.07–55.2, p = 0.043). Among patients treated for remission maintenance, remission at week 12 was maintained among 83.3% of patients. We conclude that the CDED may be a promising intervention for multiple CD presentations and indications. These findings should be further validated in larger, prospective, controlled studies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.
- Department of Gastroenterology and Liver Diseases, Tel Aviv Medical Center, Tel Aviv 6423906, Israel.
- Nutrition and Dietetics Department, Tel Aviv Medical Center, Tel Aviv 6423906, Israel.
ORCID-Profile: Yulia Ron, Ayal Hirsch
Förderung
- Nestlé
Zitieren
APA
Fliss-Isakov, N., Aviv Cohen, N., Bromberg, A., Elbert, G., Anbar, R., Ron, Y., Hirsch, A., Thurm, T., & Maharshak, N. (2023). Crohn’s Disease Exclusion Diet for the Treatment of Crohn’s Disease: Real-World Experience from a Tertiary Center. Journal of Clinical Medicine, 12(16), 5428. https://doi.org/10.3390/jcm12165428
Vancouver
Fliss-Isakov N, Aviv Cohen N, Bromberg A, Elbert G, Anbar R, Ron Y, et al. Crohn’s Disease Exclusion Diet for the Treatment of Crohn’s Disease: Real-World Experience from a Tertiary Center. Journal of Clinical Medicine. 2023;12(16):5428. doi:10.3390/jcm12165428
BibTeX
@article{FlissIsakov2023,
author = {Fliss-Isakov, Naomi and Aviv Cohen, Nathaniel and Bromberg, Ahuva and Elbert, Gal and Anbar, Ronit and Ron, Yulia and Hirsch, Ayal and Thurm, Tamar and Maharshak, Nitsan},
title = {Crohn’s Disease Exclusion Diet for the Treatment of Crohn’s Disease: Real-World Experience from a Tertiary Center},
journal = {Journal of Clinical Medicine},
year = {2023},
volume = {12},
number = {16},
pages = {5428},
doi = {10.3390/jcm12165428}
}
EUVIMED